127
Views
41
CrossRef citations to date
0
Altmetric
Original Article

Interactions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells

, , , &
Pages 1731-1739 | Received 20 Feb 2004, Published online: 03 Aug 2009

References

  • Kadin, M.E. (1994) "Pathology of Hodgkin's disease", Current Opinion in Oncology, 6, 456–463.
  • Harris, N.L. (1999) "Hodgkin's disease: classification and differ-ential diagnosis", Modern Pathology, 12, 159— 175.
  • Gruss, R.I., Herrmann, F. and Drexler, H.G. (1994) "Hodgkin's disease: a cytokine-producing tumor", Crit. Rev. Oncog., 5, 473 — 538.
  • Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., et al. (1995) "Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell line", Blood, 85, 780— 789.
  • Skinnider, B.F. and Mak, T.W. (2002) "The role of cytokines in classical Hodgkin lymphoma", Blood, 99, 4283–4297.
  • Pinto, A., Aldinucci, D., Gloghini, A., Zagonel, V., Degan, M., Improta, S., et al. (1996) "Human Eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line", Blood, 88, 3299 — 3305.
  • Aldinucci, D., Poletto, D., Nanni, P., Degan, M., Gloghini, A., Di Francia, R., et al. (2002) "Hodgkin and Reed-Sternberg cells express functional c-kit receptors and interact with primary fibroblasts from Hodgkin's disease-involved lymph nodes through soluble and membrane-bound stem cell factor", Br. J. Haematol., 118, 1055–1064.
  • Aldinucci, D., Poletto, D., Gloghini, A., Nanni, P., Degan, M., Per, T., et al. (2002) "Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells", Am. J. Pathol., 160, 585 — 596.
  • Skinnider, B.F., Kapp, U. and Mak, T.W. (2002) "The role of interleukin 13 in classical Hodgkin lymphoma", Leuk. Lymphoma, 43, 1203–1210.
  • Maggio, E., van den Berg, A., Diepstra, A., Kluiver, J., Visser, L. and Poppema, S. (2002) "Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues", Ann. OncoL, 13, 52–56.
  • Fischer, M., Juremalm, M., Olsson, N., Backlin, C., Sundstrom, C., Nilsson, K., et al. (2003) "Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue", Int. J. Cancer, 107, 197 — 201.
  • Poppema, S. (1996) "Immunology of Hodgkin's disease", Baillieres Clinical Haematology, 9, 447–457.
  • Gruss, Hi., Pinto, A., Duyster, J., Poppema, S. and Herrmann, F. (1997) "Hodgkin's disease: a tumor with disturbed immunological pathways", Immunology Today, 18, 156–163.
  • Pinto, A., Gattei, V., Zagonel, V., Aldinucci, D., Degan, M., De Julius, A., et al. (1998) "Hodgkin's disease: a disorder of dysregulated cellular cross-talk", Biotherapy, 10, 309 — 320.
  • Gloghini, A., Volpe, R. and Carbone, A. (1990) "Vimentin immunostaining in fibroblastic reticulum cells within human reactive and neoplastic lymphoid tissue", Human Pathology, 21, 792— 798.
  • Ohshima, K., Sugihara, M., Suzumiya, J., Haraoka, S., Kanda, M., Shimazaki, K., et al. (1999) "Basic fibroblast growth factor and fibrosis in Hodgkin's disease", PathoL Res. Pract., 195, 149 — 155.
  • Ward, PA. and Hunninghake, G.W. (1998) "Lung inflammation and fibrosis", Am. J. Respir. Crit. Care Med., 157, 123–129.
  • Sime, P.J. and O'Reilly, K.M. (2001) "Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment", Clin. ImmunoL, 99, 308 — 319.
  • Postlethwaite, A.E., Holness, M.A., Katai, H. and Raghow, R. (1992) "Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4", J. Clin. Invest., 90, 1479 — 1485.
  • Gillery, P., Fertin, C., Nicolas, J.F., Chastang, F., Kalis, B., Banchereau, J., et al. (1992) "Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis", FEBS Lett., 18, 302, 231–234.
  • Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W. and Wynn, T.A. (1999) "An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory re-sponse", J. Clin. Invest., 104, 777–785.
  • Oriente, A., Fedarko, N.S., Pacocha, SE., Huang, S.K., Lichten-stein, L.M. and Essayan, D.M. (2000) "Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts", J. PharmacoL Exp. Ther., 292, 988–994.
  • Lee, C.G., Homer, R.J., Cohn, L., Link, H., Jung, S., Craft, J.E., et al. (2002) "Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways", J. Biol. Chem., 277, 35466— 35474.
  • Gharaee-Kermani, M., Denholm, EM. and Phan, S.H. (1996) "Costimulation of fibroblast collagen and transforming growth factor betal gene expression by monocyte chemoattractant protein-1 via specific receptors", J. Biol. Chem., 271, 17779 — 17784.
  • Gharaee-Kermani, M. and Phan, S.H. (1998) "The role of eosinophils in pulmonary fibrosis", Int. J. MoL Med., 1, 43–53.
  • Ohshima, K., Akaiwa, M., Umeshita, R., Suzumiya, J., Izuhara, K. and Kikuchi, M. (2001) "Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involve-ment in fibrosis", Histopathology, 38, 368–375.
  • Bun, C., Korner, M., Scharli, P., Cefai, D., Uguccioni, M., Mueller, C., et al. (2001) "CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease", Blood, 97, 1543 — 1548.
  • Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K. and Takizawa, H. (2003) "Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro", Int. Arch. Allergy ImmunoL, 132, 168 — 176.
  • Kelly, M., Kolb, M., Bonniaud, P. and Gaulclie, J. (2003) "Re-evaluation of fibrogenic cytokines in lung fibrosis", Curr. Pharm. Des., 9, 39 — 49.
  • Marcopoulou, C.E., Vavouraki, H.N., Dereka, X.E. and Vrotsos, I.A. (2003) "Proliferative effect of growth factors TGF-betal, PDGF-BB and rhBMP-2 on human gingival fibroblasts and periodontal ligament cells", J. Int. Acad. Periodontol., 5, 63–70.
  • Takehara, K. (2000) "Growth regulation of skin fibroblasts", J. DermatoL Sci., 24, (Suppl 1),S70–77.
  • Newcom, S.R. and Gu, L. (1995) "Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease", J. Clin. PathoL, 48, 160–163.
  • Newcom, S.R., Kadin, M.E., Ansari, A.A. and Diehl, V. (1988) "L-428 nodular sclerosing Hodgkin's cell secretes a unique transform-ing growth factor-beta active at physiologic pH", J. Clin. Invest., 82, 1915–1921.
  • Kadin, M.E., Agnarsson, B., Ellingsworth, L.R. and Newcom, S.R. (1990) "Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease", Am. J. PathoL, 136, 1209 — 1214.
  • Kadin, M., Butmarc, J., Elovic, A. and Wong, D. (1993) "Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease", Am. J. Pathol., 142, 11–16.
  • Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., et al. (1994) "The CD40 antigen and its ligand", Annu. Rev. Immunol., 12, 881–922.
  • Brouty-Boye, D., Pottin-Clemenceau, C., Doucet, C., Jasmin, C. and Azzarone, B. (2000) "Chemokines and CD40 expression in human fibroblasts", Eur. J. Immunol., 30, 914 — 919.
  • Fries, K.M., Sempowski, G.D., Gaspari, A.A., Blieden, T., Looney, R.J. and Phipps, R.P. (1995) "CD40 expression by human fibroblasts", Clin. Immunol. Immunopathol., 77, 42–51.
  • Ward, P.A. and Hunninghake, G.W. (1998) "Lung inflammation and fibrosis", Am. J. Respir. Crit. Care Med., 157, 123— 129.
  • Companjen, A.R., van der Wel, L.I., Boon, L., Prens, E.P. and Laman, J. D. (2002) "CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-I", Int. Immunol., 14, 669 — 676.
  • Wassenaar, A., Verschoor, T., Kievits, F., Den Hartog, M.T., Kapsenberg, M.L., Everts, V., et al. (1999) "CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts", Clin. Exp. ImmunoL, 115, 161 — 167.
  • King, A.E., Kelly, R.W., Critchley, HOD., Malmstrom, A., Sennstrom, M. and Phipps, R.P. (2001) "CD40 expression in uterine tissues: a key regulator of cytokine expression by fibro-blasts", J. Clin. EndocrinoL MeTable., 86, 405–412.
  • Yellin, M.J., Winikoff, S., Fortune, S.M., Baum, D., Crow, M.K., Lederman, S., etal. (1995) "Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation", J. Leukoc. BioL, 58, 209 — 211.
  • Atamas, S.P., Luzina, I.G., Dai, H., Wilt, S.G. and White, B. (2002) "Synergy between CD40 ligation and IL-4 on fibroblast prolifera-tion involves IL-4 receptor signalling", J. Immunol., 168, 1139 — 1145.
  • Zhang, Y., Cao, H.J., Graf, B., Meekins, H., Smith, T.J. and Phipps, R.P. (1998) "CD40 engagement up-regulates cyclooxygen-ase-2 expression and prostaglandin E2 production in human lung fibroblasts", J. Immunol., 160, 1053 — 1057.
  • Betz, M. and Fox, B.S. (1995) "Prostaglandin E2 inhibits production of Thl lymphokines but not of Th2 lymphokines", J. ImmunoL, 146, 108 — 113.
  • Clodi, K., Asgari, Z., Younes, M., Palmer, J.L., Cabanillas, F., Carbone, A., etal. (2002) "Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: potential therapeutic significance", Cancer, 94, 1 — 5.
  • Pinto, A., Aldinucci, D., Gloghini, A., Zagonel, V., Degan, M., Perin, V., etal., (1997) "The role of eosinophils in the pathobiology of Hodgkin's disease", Ann. OncoL, 8, 89— 96.
  • Molin, D., Edstrom, A., Glimelius, I., Glimelius, B., Nilsson, G., Sundstrom, C., et al. (2002) "Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma", Br. J. HaematoL, 119, 122–124.
  • Hartman, M.L., Piliponsky, A.M., Temkin, V. and Levi-Schaffer, F. (2001) "Human peripheral blood eosinophils express stem cell factor", Blood, 97, 1086— 1091.
  • Bargou, R.C., Mapara, M.Y., Zugck, C., Daniel, P.T., Pawlita, M., Dohner, H., et al. (1993) "Characterization of a novel Hodgkin cell line, HD-MyZ, with myelomonocytic features mimicking Hodgkin's disease in severe combined immunodeficient mice", J. Exp. Med., 177, 1257— 1268.
  • Tesch, H., Jucker, M., Klein, S., Abts, H., Gunther, A., Krueger, G.R., et al. (1992) "Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors", Leuk. Lymphoma, 7, 297— 303.
  • Kube, D., Holtick, U., Vockerodt, M., Ahmadi, T., Haier, B., Behrmann, I., et al. (2001) "STAT3 is constitutively activated in Hodgkin cell lines", Blood, 98, 762–770.
  • Ashman, L.K. (1999) "The biology of stem cell factor and its receptor C-kit", International Journal of Biochemistry and Cell Biology, 31, 1037–1051.
  • Broudy, V.C. (1997) "Stem cell factor and hematopoiesis", Blood, 90, 1345–1364.
  • Broxmeyer, H.E., Maze, R., Miyazawa, K., Carow, C., Hendrie, P.C., Cooper, S., et al. (1991) "The kit receptor and its ligand, steel factor, as regulators of hemopoiesis", Cancer Cells, 3, 480–487.
  • Mierke, C.T., Ballmaier, M., Werner, U., Manns, M.P., Welte, K. and Bischoff, S.C. (2000) "Human endothelial cells regulate survival and proliferation of human mast cells", Journal of Experimental Medicine, 192, 801–811.
  • Avraham, H., Scadden, D.T., CM, S., Broudy, V.C., Zsebo, K.M. and Groopman, J.E. (1992) "Interaction of human bone marrow fibroblasts with megakaryocytes: Role of the c-kit ligand", Blood, 80, 1679 — 1684.
  • Gattei, V., Aldinucci, D., Quinn, J.M., Degan, M., Cozzi, M., Perin, V., et al. (1996) "Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor", Cell Growth & Differentiation, 7, 753–763.
  • Pietsch, T., Kyas, U., Steffens, U., Yakisan, E., Hadam, M.R., Ludwig, W.D., etal. (1992) "Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors", Blood, 80, 1199–1206.
  • Timeus, F., Crescenzio, N., Valle, P., Pistamiglio, P., Piglione, M., Garelli, E., et al. (1997) "Stem cell factor suppresses apoptosis in neuroblastoma cell lines", Experimental Haematology, 25, 1253 — 1260.
  • Ricotti, E., Fagioli, F., Garelli, E., Linari, C., Crescenzio, N., Horenstein, A.L., et al. (1998) "c-kit is expressed in Soft Tissue Sarcoma of neuroectodermis origin and its ligand prevents apoptosis of neoplastic cells", Blood, 91, 2397 — 2405.
  • Landuzzi, L., De Giovanni, C., Nicoletti, G., Rossi, I., Ricci, C., Astolfi, A., et al. (2000) "The metastatic ability of Ewing's sarcoma cells is modulated by Stem Cell Factor and by its receptor c-kit", American Journal of Pathology, 157, 2123 — 2131.
  • Pinto, A., Gloghini, A., Gattei, V., Aldinucci, D., Zagonel, V. and Carbone, A. (1994) "Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30 + anaplastic large cell lymphomas", Blood, 83, 785–792.
  • Gruss, Hi., Brach, M.A., Drexler, HG., Bross, K.J. and Herrmann, F. (1992) "Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells", Cancer Research, 52, 1026— 1031.
  • Merz, H., Houssiau, F.A., Orscheschek, K., Renauld, J.F., Fliedner, A., Herin, M., et al. (1991) "Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma", Blood, 78, 1311— 1317.
  • Aldinucci, D. and Gattei, V. (2003) "The role of interleukin-3 and stem cell factor in classical Hodgkin disease", Blood, 101, 376 — 377.
  • Gommerman, J.L. and Berger, S.A. (1998) "Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx", Blood, 91, 189 1— 1900.
  • Fry, Ti. and Mackall, C.L. (2002) "Interleukin-7: from bench to clinic", Blood, 99, 3892–38904.
  • Foss, H.D., Hummel, M., Gottstein, S., Ziemann, K., Falini, B., Herbst, H., et al., (1995) "Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease", Am J Pathol., 146, 33 — 39.
  • Trumper, L., Jung, W., Dahl, G., Diehl, V., Gause, A. and Pfreundschuh, M. (1994) "Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease", Ann. °flea, 5, 93–96.
  • Gorschluter, M., Bohlen, H., Hasenclever, D., Diehl, V. and Tesch, H. (1995) "Serum cytokine levels correlate with clinical parameters in Hodgkin's disease", Ann. Oncol., 6, 477–482.
  • Touw, I., Pouwels, K., van Agthoven, T., van Gurp, R., Budel, L., Hoogerbrugge, H., et al. (1990) "Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia", Blood, 75, 2097 — 2101.
  • Hsu, S.M., Waldron, J., Xie, S.S. and Hsu, P.L. (1995) "Hodgkin's Disease and Anaplastic Large Cell Lymphoma Revisited. 1. unique cytokine and cytokine receptor profile distinguished from that of non-hodgkin's lymphomas", J. Biomed. Sci., 2, 302— 313.
  • Kishimoto, T., Akira, S., Narazaki, M. and Taga, T. (1995) "Interleukin-6 family of cytokines and gp130", Blood, 86,1243 — 1254.
  • Klein, B., Tarte, K., Jourdan, M., Mathouk, K., Moreaux, J., Jourdan, E., et al. (2003) "Survival and proliferation factors of normal and malignant plasma cells", Int. J. Hematol., 78, 106–113.
  • Trikha, M., Corringham, R., Klein, B. and Rossi, J.F. (2003) "Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence", Clin. Cancer Res., 9, 4653–4665.
  • Reynolds, G.M., Billingham, Li., Gray, L.J., Flavell, JR., Najafipour, S., Crocker, J., et al. (2002) "Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease", Br. J. Haematol., 118, 195–201.
  • Tesch, H., Jucker, M., Klein, S., Abts, H., Gunther, A., Krueger, G.R., et al. (1992) "Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors", Leuk. Lymphoma, 7, 297— 303.
  • Iwata, M., Graf, L., Awaya, N. and Torok-Storb, B. (2002) "Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein", Blood, 100, 1318–1325.
  • Teruya-Feldstein, J., Tosato, G. and Jaffe, E.S. (2000) "The role of chemokines in Hodgkin's disease", Leuk. Lymphoma, 38, 363–371.
  • Romagnani, S. (2002) "Cytokines and chemoattractants in allergic inflammation", Mol. Immunol., 38, 881 —885.
  • Teruya-Feldstein, J., Jaffe, ES., Burd, P.R., Kingma, D.W., Setsuda, J.E. and Tosato, G. (1999) "Differential chemokine expression in tissues involved by Hodgkin's disease: direct correla-tion of eotaxin expression and tissue eosinophilia", Blood, 93, 2463–2470.
  • Jundt, F., Anagnostopoulos, I., Bommert, K., Emmerich, F., Muller, G., Foss, H.D., et al. (1999) "Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils", Blood, 94, 2065 — 2071.
  • Levi-Schaffer, F., Garbuzenko, E., Rubin, A., Reich, R., Pickholz, D., Gillery, P., et al. (1999) "Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta)", Proc. Natl. Acad. Sci. USA, 96, 9660–9665.
  • Axdorph, U., Porwit-MacDonald, A., Grimfors, G. and Bjorkholm, M. (2001) "Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease", Leuk. Lymphoma, 42, 1055–1065.
  • van Roozendaal, CE., van Ooijen, B., Klijn, J.G., Claassen, C., Eggermont, AM., Henzen-Logmans, S.C., et al. (1998) "Stromal influences on breast cancer cell growth", Br. J. Cancer, 65, 77–81.
  • Gache, C., Berthois, Y., Cvitkovic, E., Martin, P.M. and Saez, S. (1999) "Differential regulation of normal and tumoral breast epithelial cell growth by fibroblasts and 1,25-dihydroxyvitamin D3", Breast Cancer Res. Treat., 55, 29— 39.
  • Gache, C., Berthois, Y., Martin, P.M. and Saez, S. (1998) "Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture", In Vitro Cell Dev. Biol. Anim., 34, 347–351.
  • Noel, A. and Foidart, J.M. (1998) "The role of stroma in breast carcinoma growth in vivo", J. Mammary Gland Biol. Neoplasia, 3, 215 —225.
  • Cunha, G.R., Hayward, SM. Wang, Y.Z. and Ricke, WA. (2003) "Role of the stromal microenvironment in carcinogenesis of the prostate", Int. J. Cancer, 20, 107, 1–10.
  • De Weyer, 0. and Marcel, M. (2003) "Role of tissue stroma in cancer cell invasion", J. Pathol., 200, 429–447.
  • Moinfar, F., Man, Y.G., Arnould, L., Bratthauer, G.L., Ratschek, M. and Tavassoli, F.A. (2000) "Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis", Cancer Res., 60, 2562— 2566.
  • Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. and Stryck-mans, P. (1998) "Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood, 91, 2387–2396.
  • Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. and Hoffbrand, A.V. (1996) "Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro", Br. J. Haematol., 92, 97–103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.